Search alternatives:
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a marked » _ marked (Expand Search), a marker (Expand Search), a market (Expand Search)
a large » _ large (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a marked » _ marked (Expand Search), a marker (Expand Search), a market (Expand Search)
a large » _ large (Expand Search)
-
1
-
2
-
3
-
4
(A–D) Representative immunoblots for the reporter assays shown in Fig 4A–D.
Published 2025Subjects: -
5
-
6
-
7
-
8
HSF2 is a positive regulator of EBV spontaneous lytic cycle in gastric epithelial cells.
Published 2025Subjects: -
9
S1 File -
Published 2025“…Culturing at high glucose increased both nNOS and iNOS activities inducing a marked decrease in GSIS in a following short-term incubation at high glucose. …”
-
10
-
11
-
12
-
13
-
14
The Laboratory Animal Flow Diagram.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
15
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
16
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
17
The structures of T3 and Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
18
Synthesis process of Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
19
ESI-HRMS spectra for Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
20